0

Multiple Sclerosis Collection
 1-5 of 5 Articles
ACP Journal Club |  18 March 2014
Review: In relapsing–remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates
Brian G. Weinshenker, MD, FRCP(C)
Ann Intern Med. 2014;160(6):JC5. doi:10.7326/0003-4819-160-6-201403180-02005
ACP Journal Club |  18 May 2010
Oral fingolimod was more effective than intramuscular interferon for relapsing–remitting multiple sclerosis
James Hughes, MD
Ann Intern Med. 2010;152(10):JC5-6. doi:10.7326/0003-4819-152-10-201005180-02006
ACP Journal Club |  18 May 2010
Oral fingolimod was more effective than placebo for relapsing–remitting multiple sclerosis
James Hughes, MD
Ann Intern Med. 2010;152(10):JC5-7. doi:10.7326/0003-4819-152-10-201005180-02007
ACP Journal Club |  18 May 2010
Oral cladribine was more effective than placebo for relapsing–remitting multiple sclerosis
James Hughes, MD
Ann Intern Med. 2010;152(10):JC5-8. doi:10.7326/0003-4819-152-10-201005180-02008
ACP Journal Club |  19 January 2010
Glatiramer acetate delayed conversion to multiple sclerosis in patients with clinically isolated syndrome
J.E. Rick Paulseth, MD
Ann Intern Med. 2010;152(2):JC1-10. doi:10.7326/0003-4819-152-2-201001190-02010
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)